About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
R
Overview of Hematopoietic Cell Transplantation
By
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
FEATURING
Rachel Salit
February 22, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:48
Tumor Lysis Syndrome
Strategies for Preventing and Managing Tumor Lysis Syndrome-Associat…
Feat.
M. Geyer
Featured Video
18:47
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations in R/R CLL - A Patient Case Study
Feat.
J. N. Allan
Related Content
AUTOPLAY
ON
18:26
William Schaffner
Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
50:34
Scripps MD Anderson Cancer Center
The Cure of Leukemias in the Next Decade: An Optimist’s View
Feat.
H. Kantarjian
15:52
Lilly
BTK Inhibition for Patients with MCL: Safety and Efficacy Data
Feat.
J. Pagel
12:36
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in…
Feat.
A. Patel
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
10:04
Stephen M. Ansell
NCCN Guidelines for the Treatment of cHL: A New Standard of Care
03:17
Insights from 2023 IMS Annual Meeting
IMS 2023 Insights: "Highlights From the International Myeloma S…
Feat.
J. Richter
04:15
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…
Feat.
M. Gertz
04:02
Michael Burke
Updated Results from the BLAST and TOWER Studies: Safety and Efficac…
12:28
Roswell Park Comprehensive Cancer Center
Current Landscape of R/R AML Treatment
Feat.
E. Wang
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
02:52
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of …
Feat.
M. Amaya
10:27
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…
Feat.
J. DiPersio
05:56
ASH 2022 Conference Coverage
ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalido…
Feat.
G. Morgan
13:18
Insights from 2023 IMS Annual Meeting
Highlights and Key Takeaways From the 2023 International Myeloma Soc…
Feat.
A. Jakubowiak
15:45
SOHO 2022 Tenth Annual Meeting
SOHO 2022: How Do We Overcome Resistance to Venetoclax in AML
Feat.
M. Konopleva
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
